Lacktman Comments on Confusion Over DEA’s Telemedicine Rulemaking

22 April 2019 Politico News
Partner Nate Lacktman was quoted in a Politico article, “HHS extends interoperability comment window,” about lingering confusion over an expected Drug Enforcement Administration rule that is supposed to clarify when doctors can register to prescribe controlled substances via telemedicine.

Lacktman said it is not clear what will be in the rule, which is expected to come out in October. If the rule isn’t specific enough or if it restricts prescribing to certain specialties or substances, clinicians might not feel comfortable prescribing virtually, he said.

Related Services


California Establishes Fund to Combat Wildfire Threats
15 July 2019
Renewable Energy Outlook
There’s No Place Like Home – But Is That a Reasonable Accommodation?
15 July 2019
Labor & Employment Law Perspectives
Beginning Construction Continuity Safe Harbor Extended for National Security Concerns
15 July 2019
Renewable Energy Outlook
Manufacturing MarketTrends | July 2019, Issue 2
12 July 2019
Manufacturing MarketTrends
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
MAGI’s Clinical Research Conference
29 October 2019
Las Vegas, NV
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ